About Anaptysbio (ANAB)
AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more
- USD21.02
- USD22.74
- USD21.02
- USD27.50
- -2.80%
- 17M
- 719.62k
- 374.79k
- 574M
- 13.36
- 0.10%
Stock News
3 hours ago
Asian Stocks Track US Peers Higher, Led By Japan: Markets Wrap
Yahoo
yesterday
Cramer says Apple's Monday rally doesn't have 'staying power' after analyst upgrade
CNBC
yesterday
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
CNBC
yesterday
Dow Jones Up As Donald Trump Stock Surges; Cathie Wood Loads Up On This AI Stock Amid 26% Plunge
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
